Abstract
Anaemia is common in patients receiving chemotherapy, causing symptoms that have a major impact on quality of life (QoL). Epoetin beta rapidly increases haemoglobin (Hb) levels and improves QoL in anaemic patients with a variety of tumours. This was a randomized, double-blind, parallel-group, dose-finding study assessing the efficacy and safety of once-weekly epoetin beta in patients with solid tumours receiving chemotherapy. Adult patients with anaemia (Hb < 11 g/dL) were randomized to receive epoetin beta 30,000 IU or 20,000 IU once weekly for 12 weeks. All patients received oral iron supplementation. Haemoglobin levels, transfusion need and QoL [Functional Assessment of Cancer Therapy-fatigue (FACT-F) subscale score] were assessed at regular intervals. Fifty patients were randomized; 30 patients received epoetin beta 30,000 IU once weekly and 20 received 20,000 IU once weekly. Mean (+/- SD) increase in Hb from baseline to week 12 was 1.75 +/- 2.15 g/dL in the 30,000 IU group (P = 0.008 vs. baseline) and 1.04 +/- 1.75 g/dL in the 20,000 IU group (non-significant). Haemoglobin response (increase in Hb >or=2 g/dL from baseline) was observed in 78.3% of patients receiving epoetin beta 30,000 IU and 66.7% receiving epoetin beta 2...Continue Reading
References
Apr 24, 1976·Lancet·T J Priestman, M Baum
Jun 14, 1990·The New England Journal of Medicine·C B MillerJ L Spivak
Nov 1, 1988·Psychological Medicine·H M McCormackS Sheather
Feb 1, 1997·Journal of Pain and Symptom Management·S B YellenE Kaplan
May 29, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C OberhoffH Zwierzina
Nov 20, 1998·Medical Oncology·W W ten Bokkel HuininkB Ehmer
May 27, 1999·BMJ : British Medical Journal·D Provan
Jan 19, 2000·British Journal of Cancer·P J Barrett-LeeE Wager
Jul 29, 2000·Cancer Treatment Reviews·S MercadanteS Filosto
May 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anders OsterborgUNKNOWN Epoetin Beta Hematology Study Group
Aug 24, 2002·BMJ : British Medical Journal·Philip P Mortimer
Sep 5, 2002·Cancer·Jeffrey CrawfordJohn A Glaspy
Apr 2, 2003·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·Jean-Pierre Allain
Apr 3, 2003·British Journal of Cancer·M BoogaertsUNKNOWN Epoetin beta QOL Working Group
Jul 25, 2003·British Journal of Haematology·Mario CazzolaBertrand Coiffier
Nov 11, 2003·Current Medical Research and Opinion·Nick Bosanquet, Keith Tolley
Sep 30, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C BokemeyerP Soubeyran
Jul 15, 2005·Oncology·Eric Pujade-Lauraine, Clare Topham
Dec 24, 2005·British Journal of Haematology·Christopher A Ludlam, Marc L Turner